Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Adair

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersD S Alberts, P T Fanta, K L Running, et al.
BMC Public Health|November 7, 2025
Perceived barriers to and facilitators of physical activity, using the COM-B model for behavioural change, in people with chronic pain: a qualitative evaluation of patient and stakeholder perspectivesCassie Higgins, P M Dall, C Leese, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 12, 2006
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptakeKristi S Rau, Elisabeth Birdsall, Trent J Volz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersD S Alberts, P T Fanta, K L Running, et al.
BMC Public Health|November 7, 2025
Perceived barriers to and facilitators of physical activity, using the COM-B model for behavioural change, in people with chronic pain: a qualitative evaluation of patient and stakeholder perspectivesCassie Higgins, P M Dall, C Leese, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 12, 2006
Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptakeKristi S Rau, Elisabeth Birdsall, Trent J Volz, et al.
Pageof 2